Effect of applying a treatment threshold in a population. An example of pulmonary tuberculosis in Rwanda

Journal of Evaluation in Clinical Practice

Volumn 16, Issue 3, 2010, Pages 499-508

  Van Den Ende, Jef ^a,b   Mugabekazi, Julie ^c   Moreira, Juan ^a   Seryange, Eric ^c   Basinga, Paulin ^d   Bisoffi, Zeno ^e   Menten, Joris ^a   Boelaert, Marleen ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c Centre Hospitalier Universitaire de Kigali   (Rwanda)

^d UNIVERSITY OF RWANDA   (Rwanda)

^e Centro Per Le Malattie Tropicali   (Italy)

Author keywords

Decision making; Rwanda; Threshold; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST; COUGHING; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCEPTIVE THRESHOLD; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RWANDA; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION;

ADOLESCENT; ADULT; CLUSTER ANALYSIS; COHORT STUDIES; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RWANDA; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 77952919227     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2009.01150.x     Document Type: Article

References (37)

1. World Health Organisation 2002) Global Tuberculosis Control. Surveillance, Planning, Finance.
2. Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J. Dye, C. (2003) Tuberculosis. Lancet, 362, 887 899.
3. Samb, B., Henzel, D., Daley, C. L., et al. (1997) Methods for diagnosing tuberculosis among in-patients in eastern Africa whose sputum smears are negative. The International Journal of Tuberculosis and Lung Disease, 1, 25 30.
4. Barnes, P. F. Cave, M. D. (2003) Molecular epidemiology of tuberculosis. The New England Journal of Medicine, 349, 1149 1156.
5. Siddiqi, K., Lambert, M. L. Walley, J. (2003) Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. The Lancet Infectious Diseases, 3, 288 296.
6. Colebunders, R. Bastian, I. (2000) A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. The International Journal of Tuberculosis and Lung Disease, 4, 97 107.
7. Kanaya, A. M., Glidden, D. V. Chambers, H. F. (2001) Identifying pulmonary tuberculosis in patients with negative sputum smear results. Chest, 120, 349 355.
8. Pauker, S. G. Kassirer, J. P. (1975) Therapeutic decision making: a cost-benefit analysis. The New England Journal of Medicine, 293, 229 234.
9. Pauker, S. G. Kassirer, J. P. (1980) The threshold approach to clinical decision making. The New England Journal of Medicine, 302, 1109 1117.
10. Basinga, P., Bisoffi, Z., Moreira, J., Bisig, B. Van den Ende, J. (2007) Why are clinicians reluctant to treat smear-negative tuberculosis? An inquiry about treatment thresholds in Rwanda. Medical Decision Making, 27, 53 60.
11. Metz, C. E. (1978) Basic principles of ROC analysis. Seminars in Nuclear Medicine, 8, 283 298.
12. Zweig, M. H. Campbell, G. (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry, 39, 561 577.
13. Dekay, M. L. (2006) The difference between Blackstone-Like error ratios and the probabilistics standards of proof. Law and Social Inquiry, 21, 95 132.
14. Apers, L., Mutsvangwa, J., Magwenzi, J., Chigara, N., Butterworth, A., Mason, P. Van der, Stuyft, P. (2003) A comparison of direct microscopy, the concentration method and the mycobacteria growth indicator tube for the examination of sputum for acid-fast bacilli. The International Journal of Tuberculosis and Lung Disease, 7, 376 381.
15. Crampin, A. C., Floyd, S., Mwaungulu, F., Black, G., Ndhlovu, R., Mwaiyeghele, E., Glynn, J. R., Warndorff, D. K. Fine, P. E. (2001) Comparison of two versus three smears in identifying culture-positive tuberculosis patients in a rural African setting with high HIV prevalence. The International Journal of Tuberculosis and Lung Disease, 5, 994 999.
16. Siddiqi, K., Walley, J., Khan, M. A., Shah, K. Safdar, N. (2006) Clinical guidelines to diagnose smear-negative pulmonary tuberculosis in Pakistan, a country with low-HIV prevalence. Tropical Medicine and International Health, 11, 323 331.
17. Goodman, L. (1974) The analysis of systems of qualitative variables when some of the variables are unobservable. Part I - a modified latent structure approach. The American Journal of Sociology, 79, 1179 1259.
18. Rindskopf, D. Rindskopf, W. (1986) The value of latent class analysis in medical diagnosis. Statistics in Medicine, 5, 21 27.
19. Formann, A. K. Kohlmann, T. (1996) Latent class analysis in medical research. Statistical Methods in Medical Research, 5, 179 211.
20. Mugabekazi, J., Boelaert, M., Sarushi, J., Seruyange, E., Basinga, P., Musemakweli, A., Van der Stuyft, P., Bisoffi, Z., Moreira, J. Van den Ende, J. (2007) Accuracy of clinical signs in the diagnosis of pulmonary tuberculosis: comparison of three reference standards using data from a tertiary care centre in Rwanda. The Open Tropical Medicine Journal, 1, 1 7.
21. Dendukuri, N. Joseph, L. (2001) Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics, 57, 158 167.
22. Grzybowski, S. Enarson, D. (1978 Results in pulmonary tuberculosis patients under various treatment program conditions Bulletin of the International Union against Tuberculosis, 53, 70 75.
23. World Health Organization (1974) Tuberculosis in a rural population of South India: a five-year epidemiological study. Bulletin of the World Health Organization, 51, 473 488.
24. Springett, V. H. (1971) Ten-year results during the introduction of chemotherapy for tuberculosis. Tubercle, 52, 73 87.
25. Zierski, M. Bek, E. (1980) Side-effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study. Tubercle, 61, 41 49.
26. Gonzalez Montaner, L. J., Dambrosi, A., Manassero, M. Dambrosi, V. M. (1982) Adverse effects of antituberculosis drugs causing changes in treatment. Tubercle, 63, 291 294.
27. Combs, D. L., O'Brien, R. J. Geiter, L. J. (1990) USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results. Annals of Internal Medicine, 112, 397 406.
28. Steele, M. A., Burk, R. F. DesPrez, R. M. (1991) Toxic hepatitis with isoniazid and rifampin. A meta-analysis. Chest, 99, 465 471.
29. Ormerod, L. P. Horsfield, N. (1996) Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tubercle and Lung Disease, 77, 37 42.
30. Garner, P. Holmes, A. (2002) Tuberculosis. Clinical Evidence, 7, 747 756.
31. Yee, D., Valiquette, C., Pelletier, M., Parisien, I., Rocher, I. Menzies, D. (2003) Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. American Journal of Respiratory and Critical Care Medicine, 167, 1472 1477.
32. Van-Hest, R., Baars, H., Kik, S., van, Gerven, P., Trompenaars, M. C., Kalisvaart, N., Keizer, S., Borgdorff, M., Mensen, M. Cobelens, F. (2004) Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment. Clinical Infectious Diseases, 39, 488 496.
33. Djulbegovic, B., Hozo, I., Schwartz, A. McMasters, K. M. (1999) Acceptable regret in medical decision making. Medical Hypotheses, 53, 253 259.
34. Behr, M. A., Warren, S. A., Salamon, H., Hopewell, P. C., Ponce, de Leon, Daley, C. L. Small, P. M. (1999) Transmission of mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet, 353, 444 449.
35. Kopelman, R. I., Wong, J. B. Pauker, S. G. (1999) Clinical problem-solving. A little math helps the medicine go down. The New England Journal of Medicine, 341, 435 439.
36. Mohan, C. I., Bishai, D., Cavalcante, S. Chaisson, R. E. (2007) The cost-effectiveness of DOTS in urban Brazil. The International Journal of Tuberculosis and Lung Disease, 11, 27 32.
37. Moreira, J., Alarcon, F., Bisoffi, Z., Rivera, J., Salinas, R., Menten, J., Duenas, G. Van den, Ende, J. (2008) Tuberculous meningitis: does lowering the treatment threshold result in many more treated patients? Tropical Medicine and International Health, 13, 68 75.